干细胞生物药物研究进展

胚胎干细胞和成年干细胞经培养能产生更多干细胞也可定向分化成神经细胞、血细胞、肝细胞等特定类型的细胞。其中具有潜能的细胞可用来研究治疗帕金森病、糖尿病和脊髓损伤等疾病的生物药物。     

The Italian Way to Stem Cell Research: Rethinking the Role of Catholic Religion in Shaping Italian Stem Cell Research Regulations

Stem cell research regulations are highly variable across nations, notwithstanding shared and common ethical concerns. Dominant in political debates has been the so‐called embryo question. However, the permissibility of human embryonic stem cell (hESC) research varies among national regulatory frameworks. Scholars have explained differences by resorting to notions of political culture, traditions of ethical reasoning, discursive strategies and political manoeuvring of involved actors. Explanations based on the role of religion or other cultural structural variables are also employed. This paper analyses the emerging of the Italian regulatory framework on stem cell research using an analytical framework that considers the interplay between cultural structural features, political culture, traditions of ethical reasoning, institutional settings and the discursive and political agency of the actors involved. It aims also to explain the role of Roman Catholic Church in shaping the Italian stem cell research regulation not by treating religion as an autonomous causal factor, but through the analysis of the agency of Catholic and allied actors in the Italian political culture and institutional setting.     

Web Resources for Stem Cell Research

In this short review, we have presented a brief overview on major web resources relevant to stem cell research. To facilitate more efficient use of these resources, we have provided a preliminary rating based on our own user experience of the overall quality for each resource. We plan to update the information on an annual basis.     

胚胎干细胞的研究进展

胚胎干细胞是来源于早期胚胎内细胞团的、具有多向分化潜能的细胞,已经广泛用于生命科学的许多领域,它在医学方面的应用成为医学领域的研究热点.本文对胚胎干细胞在诱导分化、基础研究和临床应用上的研究进展进行了综述,对今后的研究方向进行了展望.     

MicroRNAs与胚胎干细胞研究

MicroRNAs(miRNAs)是一种大小约20～25个碱基的非编码小分子RNA,一般通过特异性抑制靶蛋白翻译或降解靶基因mRNA发挥负调控基因表达的作用.胚胎干细胞(embryonic stem cells,ES细胞)是从植入前早期胚胎内细胞团或原始生殖细胞中分离得到并能在体外长期培养的高度未分化的多能细胞系,在揭示胚胎早期发育机理、药物筛选、临床再生医学等领域具有广泛的应用前景.最近研究发现miRNAs在ES细胞自我更新和分化过程中均发挥着重要的调控作用,但具体调控机制尚未完全阐明.进一步深入研究miRNAs在ES细胞中的作用,全面了解ES细胞自我更新和定向分化的机制是实现ES细胞广阔临床应用前景的基础.     

单细胞技术在干细胞研究中的应用

干细胞是具有自我更新和分化潜能的异质性细胞群体。基于细胞群体水平的干细胞研究不能满足深入认识干细胞生物学本质及实际应用的需要。近年来,单细胞相关技术不断发展和成熟,并正在干细胞基础研究及其相关领域中获得迅速应用。该文以造血干细胞为主要例举,就实验研究中常用的单细胞分离、单细胞克隆分析、单细胞移植、单细胞实时定量PCR及单细胞测序等技术原理及其应用进行综述。     

Adipose-Derived Mesenchymal Stem Cell Administration Does Not Improve Corneal Graft Survival Outcome

The effect of local and systemic injections of mesenchymal stem cells derived from adipose tissue (AD-MSC) into rabbit models of corneal allograft rejection with either normal-risk or high-risk vascularized corneal beds was investigated. The models we present in this study are more similar to human corneal transplants than previously reported murine models. Our aim was to prevent transplant rejection and increase the length of graft survival. In the normal-risk transplant model, in contrast to our expectations, the injection of AD-MSC into the graft junction during surgery resulted in the induction of increased signs of inflammation such as corneal edema with increased thickness, and a higher level of infiltration of leukocytes. This process led to a lower survival of the graft compared with the sham-treated corneal transplants. In the high-risk transplant model, in which immune ocular privilege was undermined by the induction of neovascularization prior to graft surgery, we found the use of systemic rabbit AD-MSCs prior to surgery, during surgery, and at various time points after surgery resulted in a shorter survival of the graft compared with the non-treated corneal grafts. Based on our results, local or systemic treatment with AD-MSCs to prevent corneal rejection in rabbit corneal models at normal or high risk of rejection does not increase survival but rather can increase inflammation and neovascularization and break the innate ocular immune privilege. This result can be partially explained by the immunomarkers, lack of immunosuppressive ability and immunophenotypical secretion molecules characterization of AD-MSC used in this study. Parameters including the risk of rejection, the inflammatory/vascularization environment, the cell source, the time of injection, the immunosuppression, the number of cells, and the mode of delivery must be established before translating the possible benefits of the use of MSCs in corneal transplants to clinical practice.     

A Special Issue on Stem Cell Research

Stem cells possess the remarkable ability of extensive self-renewal and differentiation into specific celllineages,and they play essential roles in development and adult tissue homeostasis.Due to their criticalimportance in normal physiology and the promise for use in regenerative medicine to treat a variety ofdiseases,stem cells have attracted extensive research interest in recent years.As China's premium in-ternational journal with a broad scope in cell and molecular biology,Cell Research has witnessed moreand more submissions on stem cell research.Indeed,along with the traditional strengths of the journal inmolecular immunology,cancer biology,and plant molecular physiology,stem cell research has graduallyand naturally evolved into a new growth point of Cell Research.Reflecting the growing interest of bothour readers and authors in this exciting and expanding field,we are pleased to present this Special Issueon Stem Cell Research.     

胃癌干细胞研究进展

胃癌是仅次于肺癌的第二大致死率癌症,尽管近年来对胃癌研究有了很大进展,但由于缺乏良好的动物模型,对胃癌的发病机理仍然不是很清楚.近年的研究表明,肿瘤组织不是由均一细胞构成的,其中存在一些少量细胞可以自我更新并可以分化为肿瘤组织的其他细胞,这类细胞具有类似成体组织干细胞（tissue stem cells）的特性称之为肿瘤干细胞（cancer stem cells）.肿瘤干细胞被认为在肿瘤的生长、转移、复发中发挥着重要作用.有证据表明在胃癌组织中存在胃癌干细胞（gastric cancer stem cells）,但是对胃癌干细胞的来源仍然不是十分明确.对肿瘤干细胞的研究有助于癌症的治疗,改变目前药物针对所有癌细胞的治疗策略.     

Stem cell issue: Stem Cell Research Policies around the World

The proliferation of stem cell research, conflated with its ethical and moral implications, has led governments to attempt regulation of both the science and funding of stem cells. Due to a diversity of opinions and cultural viewpoints, no single policy or set of rules exist to govern stem cell research. Instead, each country has developed its own policy. The following map catalogs the general legal and political milleu regarding stem cell research by country.     

微流控芯片在干细胞研究中的应用

干细胞以其多潜能性和自我更新能力成为人类早期胚胎研究、干细胞治疗和组织工程修复中的主要细胞来源和种子细胞。但传统细胞研究方法难以提供干细胞生长和分化所需的复杂多层次的微环境,使研究结果与体内真实情况相差甚远,尽可能模拟和精确调控干细胞培养微环境,进而控制干细胞自我更新或分化命运,成干细胞研究的难点。微流控芯片可以更真实地模拟干细胞小生境(niche);实时可控的对单个干细胞加载剪切力和生长因子;其透明的装置可对细胞行为进行跟踪观察等研究细胞微环境中占有优势,从而受到越来越多干细胞研究者的关注。结合对微流控技术研究经验,对干细胞微环境构建所需条件进行了综述,总结了微流控在干细胞研究中所取得的成果,并展望了微流控技术在干细胞研究中的应用前景。     

诱导多能干细胞研究进展

用4个外源基因从完全分化的人成纤维细胞诱导获得了具有胚胎干细胞特性的诱导多能干细胞(iPS细胞),成功逆转了细胞单向发育的规则,取得了细胞重编程和干细胞研究中的重大突破.围绕c-Myc基因和基因载体、诱导效率和外源基因替代因子等方面的研究内容,综述了自2007年人iPS细胞构建至今,国内外在改进iPS细胞诱导方法上的主要研究进展.     

干细胞、肿瘤干细胞与肿瘤

干细胞是一种具有自我更新、无限增殖和多向分化能力的细胞.而多数肿瘤是由不同增殖潜能的不均一性细胞构成.随着对干细胞的研究不断深入,使人们对肿瘤的发生机制重新进行了审视,并在造血系统、脑、肺、乳腺等部位肿瘤中发现极少量的具有与干细胞非常类似生物学特性的细胞,称之为肿瘤干细胞,它们很可能是肿瘤细胞的起源.肿瘤干细胞的提出.使得靶向性杀伤肿瘤干细胞从而使根治肿瘤和防止肿瘤复发和转移成为可能.所以研究肿瘤干细胞的起源及其与肿瘤的发生关系,成为当前研究和治疗肿瘤领域的新热点.本文就肿瘤干细胞的存在证据、干细胞与肿瘤干细胞的异同点及它们与肿瘤发生之间的关系作简要的综述.